📰 Zero Life Sciences News
Page 3 - Zero Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zero Life Sciences. Real-time updates on events, politics, business and more.
March 30, 2023
Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational
March 29, 2023
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 30,000 shares, a growth of 934.5% from the February 28th total of 2,900 shares. Based on an average trading volume of 9,100 shares, the short-interest ratio […]
March 29, 2023
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 30,000 shares, a growth of 934.5% from the February 28th total of 2,900 shares. Based on an average trading volume of 9,100 shares, […]
February 24, 2023
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) is one of 40 publicly-traded companies in the “Diagnostic Substances” industry, but how does it weigh in compared to its competitors? We will compare StageZero Life Sciences to related companies based on the strength of its dividends, profitability, analyst recommendations, risk, earnings, institutional ownership and valuation. Valuation & […]
February 7, 2023
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) is one of 40 public companies in the “Diagnostic Substances” industry, but how does it weigh in compared to its competitors? We will compare StageZero Life Sciences to similar businesses based on the strength of its dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Valuation and […]
February 2, 2023
Toronto, Ontario--(Newsfile Corp. - February 2, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving
January 12, 2023
TORONTO, ON / ACCESSWIRE / January 12, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early
November 11, 2022
TORONTO, ON / ACCESSWIRE / November 11, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its third quarter operational and financial results
August 18, 2022
Personalized support for employees through all stages of the patient journey includes advanced diagnostics, interventional support, and innovative telehealth careTORONTO, ON and RICHMOND, VA / ACCESSWIRE
August 18, 2022
TORONTO, ON and RICHMOND, VA / ACCESSWIRE / August 18, 2022 / StageZero Life Sciences, Ltd (TSX:SZLS) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the